Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

RSS icon

Report: Cultural, reimbursement barriers thwart robotic telemed adoption

Licensing, costs for technology and reimbursement for robotic telemedicine continue to impede progress, according to an article published in the January/February edition of Telemedicine and e-Health.

Study: Robotic telemedicine in NICU feasible, safe

A remote-controlled, robotic telemedicine system in the neonatal intensive care unit (NICU) is feasible and safe, according to a research published in the May editiion of Journal of Perinatology.

Study: Medical robotics industry will hit $1.3B in 2016

Advances in robotic capabilities, combined with the improving economic environment for medical services delivery and payments, are driving demand for surgical, assistive and telemedicine-based robots, according to ABI Research.

Philips, Hansen integrate x-ray, robotic catheter for cardiac arrhythmias

Royal Philips Electronics and Hansen Medical have agreed to co-develop integrated products that may simplify cardiac procedures to diagnose and treat cardiac arrhythmias.

Displaying 993 - 996 of 996

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”